Schizophrenia Research
Volume 119, Issue 1 , Pages 240-245 , June 2010

Where have all the women gone? Participant gender in epidemiological and non-epidemiological research of schizophrenia

  • Julia Longenecker

      Affiliations

    • Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, MD, United States
    • ,
  • Jamie Genderson

      Affiliations

    • Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, MD, United States
    • ,
  • Dwight Dickinson

      Affiliations

    • Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, MD, United States
    • ,
  • James Malley

      Affiliations

    • Division of Computational Bioscience, Center for Information Technology, NIH, Bethesda, MD, United States
    • ,
  • Brita Elvevåg

      Affiliations

    • Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, MD, United States
    • ,
  • Daniel R. Weinberger

      Affiliations

    • Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, MD, United States
    • ,
  • James Gold

      Affiliations

    • Division of Computational Bioscience, Center for Information Technology, NIH, Bethesda, MD, United States
    • Corresponding Author InformationCorresponding author. Maryland Psychiatric Research Center, P.O. Box 21247, Baltimore, MD, 21228, United States. Tel.: +1 410 402 7871; fax: +1 410 402 7198.

Received 11 December 2009 ,Revised 12 March 2010 ,Accepted 15 March 2010.

References 

  1. Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Archives of General Psychiatry. 2003;60(6):565–571
  2. American Psychiatric Association . DSM-III: Diagnostic and Statistical Manual of Mental Disorders. The American Psychiatric Association; 1980;
  3. Angermeyer MC, Kuhn L, Goldstein JM. Gender and the course of schizophrenia: differences in treated outcomes. Schizophrenia Bulletin. 1990;16(2):293–307
  4. Babigian H. Schizophrenia: epidemiology. In:  Kaplan H,  Freedman A,  Sadock B editor. 3 ed. Comprehensive Textbook of Psychiatry. Vol. 2:Baltimore: Williams & Wilkins; 1980;p. 643–650
  5. Bhatia T, Thomas P, Semwal P, Thelma B, et al. Differing correlates for suicide attempts among patients with schizophrenia or schizoaffective disorder in India and USA. Schizophrenia Research. 2006;86(1–3):208–214
  6. Chen YR, Swann AC, Burt DB. Stability of diagnosis in schizophrenia. American Journal of Psychiatry. 1996;153(5):682–686
  7. Covell NH, Frisman LK, Essock SM. Rates of refusal to participate in research studies among men and women. Psychiatric Services. 2003;54(11):1541–1544
  8. Grossman LS, Harrow M, Rosen C, Faull R. Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders. Psychiatric Services. 2006;57(6):844–850
  9. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology. 2003;28(Suppl 2):17–54
  10. Häfner H, Riecher A, Maurer K, Loffler W, Munk-Jorgensen P, Stromgren E. How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychological Medicine. 1989;19(4):903–918
  11. Häfner H, Behrens S, de Vry J, Gattaz W. An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Research. 1991;38(2):125–134
  12. Hambrecht M, Maurer K, Häfner H. Gender differences in schizophrenia in three cultures. Results of the WHO collaborative study on psychiatric disability. Social Psychiatry and Psychiatric Epidemiology. 1992;27(3):117–121
  13. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics. 1979;6:65–70
  14. Hunter JE. Methods of Meta-analysis: Correcting Error and Bias in Research Findings. 2004;
  15. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, et al. Schizophrenia manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine. 1992;22(SUPPL. 20):1
  16. Lewine R, Burbach D, Meltzer HY. Effect of diagnostic criteria on the ratio of male to female schizophrenic patients. American Journal of Psychiatry. 1984;141(1):84–87
  17. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine. 2004;2:13–35
  18. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews. 2008;30(1):67–76
  19. Moilanen K, Veijola J, Läksy K, Mäkikyrö T, Miettunen J, Kantojärvi L, et al. Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in Northern Finland 1966 Birth Cohort. Social Psychiatry and Psychiatric Epidemiology. 2003;38(6):305–310
  20. Phillips MR, Yang G, Li S, Li Y. Suicide and the unique prevalence pattern of schizophrenia in mainland China: a retrospective observational study. The Lancet. 2004;364(9439):1062
  21. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Medicine. 2005;2(5):0413
  22. Tsuang MT, Dempsey GM, Rauscher F. A study of ‘atypical schizophrenia’. Comparison with schizophrenia and affective disorder by sex, age of admission, precipitant, outcome, and family history. Archives of General Psychiatry. 1976;33(10):1157–1160
  23. Wahl OF. Sex bias in schizophrenia research: a short report. Journal of Abnormal Psychology. 1977;86(2):195–198
  24. Wahl OF, Hunter J. Are gender effects being neglected in schizophrenia research?. Schizophrenia Bulletin. 1992;18(2):313–318
  25. Walker Q, Rooney M, Wightman R, Kuhn C. Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry. Neuroscience. 1999;95(4):1061–1070
  26. Willhite RK, Niendam TA, Bearden CE, Zinberg J, O'Brien MP, Cannon TD. Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder. Schizophrenia Research. 2008;104(1–3):237–245
  27. World Health Organization . The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 10 ed.. Geneva: World Health Organization; 1992;

PII: S0920-9964(10)01194-1

doi: 10.1016/j.schres.2010.03.023

Schizophrenia Research
Volume 119, Issue 1 , Pages 240-245 , June 2010

Article Tools